metformin has been researched along with ro13-9904 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Millogo, GR; Savadogo, M; Zabsonré, S | 1 |
Grandgirard, D; Le, ND; Leib, SL; Muri, L; Zemp, J | 1 |
2 other study(ies) available for metformin and ro13-9904
Article | Year |
---|---|
[A hemorrhagic stroke revealing Neisseria meningitidis meningitis].
Topics: Ceftriaxone; Cerebral Hemorrhage; Emergencies; Ethmoid Sinusitis; Female; Humans; Hydrocephalus; Hyperglycemia; Meningitis, Meningococcal; Metformin; Middle Aged; Sphenoid Sinusitis; Unconsciousness | 2015 |
Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Ceftriaxone; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Hearing Loss; Hippocampus; Meningitis, Pneumococcal; Metformin; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Spiral Ganglion; Treatment Outcome | 2019 |